Theranos  – More Than Just Simple Fraud

First offered to consumers in 2013, Theranos and Walgreens advertised the Edison blood tests as being revolutionary—allowing a wide range of vital tests to be accurately performed using a smaller needle and a smaller blood sample size than traditional blood testing devices. According to reports, more than 1 million consumers paid to have their blood tested by Theranos, submitting their blood samples at Theranos facilities and at dedicated Theranos stations set up at Walgreens pharmacy locations in Arizona and California.

In May 2016, after media reports called into question the accuracy of the Edison tests and after federal regulators began investigating Theranos’ testing facilities, Theranos voided all test results for blood tests performed at its Edison facility in 2014 and 2015, and revised the test results for thousands of other blood tests it had conducted. As alleged in the lawsuit, not only did consumers who paid for these blood tests not get what they paid for, but many consumers relied on what turned out to be inaccurate and unreliable test results in obtaining medical treatment that was unnecessary or in not pursuing treatment that was necessary.